Hashimoto Encephalopathy With Status Epilepticus.

hashimoto encephalopathy hashimoto’s hypothyroidism seizure status epilepticus

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
02 Dec 2020
Historique:
entrez: 7 1 2021
pubmed: 8 1 2021
medline: 8 1 2021
Statut: epublish

Résumé

Hashimoto encephalopathy (HE) is a heterogenous neurological syndrome that can manifest with encephalopathy, seizures, headaches, and variable neuropsychiatric disturbances. The underlying mechanism remains unclear; however, autoimmune pathogenesis is suspected due to its association with autoimmune thyroid disease, high titers of anti-thyroid antibodies, and quick response to steroid therapy. We report a 59-year-old female patient with a remote history of hypothyroidism who presented with status epilepticus and complaints of chronic headaches and cognitive impairment. The presence of sharp frontal waves was identified on her EEG. The patient was initially started on anti-epileptics only; however, her headaches and memory loss escalated, further diagnostic workup was pursued, which revealed high anti-thyroid peroxidase antibodies with normal thyroid function tests. The only cerebrospinal fluid (CSF) abnormality noticed was an elevated protein concentration. MRI showed non-specific right frontal lobe pial enhancement. Remaining infectious, rheumatologic, and neurologic testing was unremarkable. The patient was started on a steroid regimen with successful resolution of symptoms and return of cognitive baseline. Hashimoto's encephalopathy is a diagnosis of exclusion; however, it should be considered in patients with high titers of anti-thyroid antibodies and neurological symptoms that cannot be explained by thorough infectious, metabolic, and autoimmune testing. It is essential to recognize this neurological entity as fast clinical improvement may be achieved with steroids and other immunotherapies.

Identifiants

pubmed: 33409091
doi: 10.7759/cureus.11857
pmc: PMC7781565
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e11857

Informations de copyright

Copyright © 2020, Sliwinska et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Arch Neurol. 2003 Feb;60(2):164-71
pubmed: 12580699
Acta Neurol Belg. 2004 Jun;104(2):80-3
pubmed: 15508271
Psychosomatics. 2011 Mar-Apr;52(2):99-108
pubmed: 21397101
J Neurol. 2006 Aug;253(8):975-84
pubmed: 16786216
Neurology. 2003 Feb 25;60(4):712-4
pubmed: 12601119
J Neurol Sci. 2015 Jan 15;348(1-2):251-2
pubmed: 25467138
J Neurol. 1996 Aug;243(8):585-93
pubmed: 8865025
Ann N Y Acad Sci. 2008 Oct;1142:254-65
pubmed: 18990131
Int J Endocrinol Metab. 2012 Spring;10(2):506-14
pubmed: 23843812
J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):455-6
pubmed: 15716552
Curr Med Chem. 2003 Oct;10(19):1945-53
pubmed: 12871097
Lancet. 1966 Sep 3;2(7462):512-4
pubmed: 4161638
J Neuropsychiatry Clin Neurosci. 2006 Winter;18(1):14-20
pubmed: 16525066
Best Pract Res Clin Endocrinol Metab. 2005 Mar;19(1):53-66
pubmed: 15826922
Br J Pharmacol. 2011 Jan;162(2):491-507
pubmed: 20955362
Eur J Endocrinol. 2014 Jun;170(6):R241-52
pubmed: 24609834
Lancet Neurol. 2016 Apr;15(4):391-404
pubmed: 26906964
Clin Neurophysiol. 2003 Jan;114(1):32-7
pubmed: 12495761
J Neurol Sci. 2004 Feb 15;217(2):165-8
pubmed: 14706219
J Clin Endocrinol Metab. 2001 Feb;86(2):947
pubmed: 11158076

Auteurs

Aleksandra Sliwinska (A)

Department of Medicine, University of Connecticut School of Medicine, Farmington, USA.

Perry Fumuso (P)

Department of Medicine, University of Connecticut School of Medicine, Farmington, USA.

Bryan Stringer (B)

Department of Medicine, University of Connecticut School of Medicine, Farmington, USA.

Muhammad Ansar (M)

Department of Endocrinology and Metabolism, University of Connecticut School of Medicine, Farmington, USA.

Jennifer Baldwin (J)

Department of Medicine, University of Connecticut School of Medicine, Farmington, USA.

Classifications MeSH